MAPT and Alzheimer disease: Emerging studies have suggested that lncRNAs are implicated in Aβ processing, aberrant Tau deposition, oxidative stress, mitochondrial dysfunction, synaptic impairment, DNA damage response, epigenetic dysfunction, and immune response, causal agents of AD pathobiology (Figure 1) [5,13,48,49].